Penumbra Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +6.0% | +1.5% | -2.9% | -3.6% | +3.7% | +3.9% | +5.1% | +4.2% | +4.7% | +3.9% | +4.0% | |
| – | +5.4% | +2.1% | +0.9% | -5.5% | +6.7% | +5.1% | +6.6% | +7.1% | +6.6% | +4.8% | +5.4% | |
| – | +66.2% | +33.2% | +29.2% | -2.7% | +15.7% | +15.9% | +12.2% | -23.9% | -41.8% | +29.1% | -14.9% | |
| – | +16.2% | +8.4% | +8.4% | -14.3% | +16.9% | +11.4% | +12.1% | +10.8% | +15.8% | +13.0% | +7.0% | |
| – | -2.3% | -4.8% | +4.6% | -12.3% | -4.8% | +0.2% | +4.5% | +4.5% | +3.6% | -3.5% | +3.9% | |
| – | +3.7% | +2.7% | -6.2% | +5.2% | +3.4% | +2.2% | +2.8% | +1.1% | -0.2% | +1.6% | +0.9% | |
| – | – | – | – | – | -0.5% | +2.4% | +4.2% | +3.1% | +7.4% | – | – | |
| – | +0.2% | -0.1% | 0.0% | +0.2% | -0.3% | +0.2% | +0.4% | 0.0% | +0.0% | -0.1% | 0.0% | |
| – | -14.0% | +8.3% | -89.8% | -0.5% | -5.9% | -0.7% | +1.3% | -2.8% | +7.2% | -12.9% | -3.4% | |
| – | +3.6% | -0.3% | -0.8% | +0.4% | +2.0% | -0.5% | +0.1% | +1.3% | +3.4% | +6.4% | +4.6% | |
| – | +4.2% | +1.1% | -1.2% | +1.5% | +3.4% | +0.2% | -0.5% | +7.5% | +8.0% | +15.6% | +10.4% | |
| – | +4.2% | +2.7% | +2.2% | +2.7% | +0.7% | +1.5% | +3.0% | +1.7% | +4.7% | +1.8% | +1.5% | |
| – | -3.0% | +19.5% | +1.1% | +1.0% | -5.5% | -0.6% | -9.7% | +6.0% | +16.5% | +25.7% | +2.5% | |
| – | +6.8% | +2.1% | -3.5% | -4.9% | +4.2% | +5.4% | +6.7% | +5.0% | +5.1% | +3.2% | +3.9% | |
| – | +67.2% | +8.2% | -41.3% | -69.6% | +130.7% | +65.4% | +45.6% | +31.7% | +24.9% | +13.7% | +12.9% | |
| – | +0.2% | +0.2% | -1.5% | +1.0% | +0.2% | -0.3% | +0.2% | +0.1% | +0.2% | +0.4% | +0.1% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.